Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Statistics

Total Valuation

OSL:NYKD has a market cap or net worth of NOK 489.82 million. The enterprise value is -186.85 million.

Market Cap	489.82M
Enterprise Value	-186.85M

Important Dates

The last earnings date was Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	May 27, 2025

Share Statistics

OSL:NYKD has 326.55 million shares outstanding. The number of shares has increased by 1.97% in one year.

Current Share Class	326.55M
Shares Outstanding	326.55M
Shares Change (YoY)	+1.97%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.96%
Owned by Institutions (%)	29.42%
Float	149.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.13
PB Ratio	0.47
P/TBV Ratio	0.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1.08
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.43

Financial Position

The company has a current ratio of 15.21, with a Debt / Equity ratio of 0.03.

Current Ratio	15.21
Quick Ratio	15.21
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-229.81

Financial Efficiency

Return on equity (ROE) is -13.40% and return on invested capital (ROIC) is -16.73%.

Return on Equity (ROE)	-13.40%
Return on Assets (ROA)	-15.08%
Return on Invested Capital (ROIC)	-16.73%
Return on Capital Employed (ROCE)	-32.91%
Revenue Per Employee	1.17M
Profits Per Employee	-2.54M
Employee Count	136
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	-72.65M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.92% in the last 52 weeks. The beta is 1.06, so OSL:NYKD's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	-72.92%
50-Day Moving Average	1.71
200-Day Moving Average	2.24
Relative Strength Index (RSI)	39.56
Average Volume (20 Days)	641,858

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:NYKD had revenue of NOK 79.85 million and -172.72 million in losses. Loss per share was -0.54.

Revenue	79.85M
Gross Profit	79.85M
Operating Income	-355.70M
Pretax Income	-245.36M
Net Income	-172.72M
EBITDA	-348.18M
EBIT	-355.70M
Loss Per Share	-0.54

Balance Sheet

The company has 708.00 million in cash and 31.33 million in debt, giving a net cash position of 676.67 million or 2.07 per share.

Cash & Cash Equivalents	708.00M
Total Debt	31.33M
Net Cash	676.67M
Net Cash Per Share	2.07
Equity (Book Value)	1.04B
Book Value Per Share	3.18
Working Capital	687.62M

Cash Flow

In the last 12 months, operating cash flow was -429.06 million and capital expenditures -920,581, giving a free cash flow of -429.98 million.

Operating Cash Flow	-429.06M
Capital Expenditures	-920,581
Free Cash Flow	-429.98M
FCF Per Share	-1.32

Margins

Gross margin is 100.00%, with operating and profit margins of -445.47% and -216.31%.

Gross Margin	100.00%
Operating Margin	-445.47%
Pretax Margin	-307.28%
Profit Margin	-216.31%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 66.67%.

Dividend Per Share	1.00
Dividend Yield	66.67%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.97%
Shareholder Yield	64.34%
Earnings Yield	-35.26%
FCF Yield	-87.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 7, 2020. It was a forward split with a ratio of 5.

Last Split Date	Jul 7, 2020
Split Type	Forward
Split Ratio	5

Scores

OSL:NYKD has an Altman Z-Score of 9.31 and a Piotroski F-Score of 2.

Altman Z-Score	9.31
Piotroski F-Score	2